Health  Vol.8 No.14 , November 2016
Fatigability Assessment Using the Fatigue Index Kliniken Schmieder (FKS) Is Not Compromised by Depression
Abstract: Background: Attractor-based kinematic gait analysis using the Fatigue Index Kliniken Schmieder (FKS), have been suggested as a sensitive tool to determine motor fatigability in persons with Multiple Sclerosis (pwMS). Hypothesis: Depression does not affect the FKS to a similar degree as in pwMS. Methods: We recruited 32 patients with major depression. Data were collected with two accelerometers attached to both ankles. Data were recorded for one minute at the beginning and at the end of the treadmill test. Attractor attributes were used to analyze the data. Results: The mean Fatigue Index Kliniken Schmieder (FKS) was 2.1. The change of the attractor (δM) was 3.7 and the change of variability (δD) was 0.6. Mean values were clearly below values of pwMS with fatigability from a previous publication. However, the individual level values from six individuals—five of them showed pain related comorbidity besides depression—fell within the lower pathological range. There was no correlation between Hamilton depression scale and the attractor attributes (δM and δD). Discussion: Depression does not affect gait as motor fatigability does in pwMS. Results from subjects with pain during the treadmill test show a moderately increased variability and moderately altered attractors.
Cite this paper: Dettmers, C. , Riegger, M. , Müller, O. and Vieten, M. (2016) Fatigability Assessment Using the Fatigue Index Kliniken Schmieder (FKS) Is Not Compromised by Depression. Health, 8, 1485-1494. doi: 10.4236/health.2016.814147.

[1]   Freal, J.E., Kraft, G.H. and Coryell, J.K. (1984) Symptomatic Fatigue in Multiple Sclerosis. Archives of Physical Medicine and Rehabilitation, 65, 135-138.

[2]   Fisk, J.D., Pontefract, A., Ritvo, P.G., Archibald, C.J. and Murray, T.J. (1994) The Impact of Fatigue on Patients with Multiple Sclerosis. The Canadian Journal of Neurological Sciences (Le journal canadien des sciences neurologiques), 21, 9-14.

[3]   Krupp, L.B. (2003) Fatigue in Multiple Sclerosis: Definition, Pathophysiology and Treatment. CNS Drugs, 17, 225-234.

[4]   Simmons, R.D. (2010) Life Issues in Multiple Sclerosis. Nature Reviews Neurology, 6, 603-610.

[5]   Simmons, R.D., Tribe, K.L. and McDonald, E.A. (2010) Living with Multiple Sclerosis: Longitudinal Changes in Employment and the Importance of Symptom Management. Journal of Neurology, 257, 926-936.

[6]   Penner, I.K., Raselli, C., Stocklin, M., Opwis, K., Kappos, L. and Calabrese, P. (2009) The Fatigue Scale for Motor and Cognitive Functions (FSMC): Validation of a New Instrument to Assess Multiple Sclerosis-Related Fatigue. Multiple Sclerosis, 15, 1509-1517.

[7]   Veauthier, C. and Paul, F. (2014) Sleep Disorders in Multiple Sclerosis and Their Relationship to Fatigue. Sleep Medicine, 15, 5-14.

[8]   Kluger, B.M., Krupp, L.B. and Enoka, R.M. (2013) Fatigue and Fatigability in Neurologic Illnesses: Proposal for a Unified Taxonomy. Neurology, 80, 409-416.

[9]   Claros-Salinas, D., Bratzke, D., Greitemann, G., Nickisch, N., Ochs, L. and Schroter, H. (2010) Fatigue-Related Diurnal Variations of Cognitive Performance in Multiple Sclerosis and Stroke Patients. Journal of the Neurological Sciences, 295, 75-81.

[10]   Neumann, M., Sterr, A., Claros-Salinas, D., Gutler, R., Ulrich, R. and Dettmers, C. (2014) Modulation of Alertness by Sustained Cognitive Demand in MS as Surrogate Measure of Fatigue and Fatigability. Journal of the Neurological Sciences, 340, 178-182.

[11]   Sehle, A., Vieten, M., Sailer, S., Mundermann, A. and Dettmers, C. (2014) Objective Assessment of Motor Fatigue in Multiple Sclerosis: The Fatigue Index Kliniken Schmieder (FKS). Journal of Neurology, 261, 1752-1762.

[12]   Vieten, M.M., Sehle, A. and Jensen, R.L. (2013) A Novel Approach to Quantify Time Series Differences of Gait Data Using Attractor Attributes. PLoS ONE, 8, e71824.

[13]   McIntyre, R.S., Konarski, J.Z., Mancini, D.A., Fulton, K.A., Parikh, S.V., Grigoriadis, S., et al. (2005) Measuring the Severity of Depression and Remission in Primary Care: Validation of the HAMD-7 Scale. Canadian Medical Association Journal, 173, 1327-1334.

[14]   Sehle, A., Vieten, M., Mundermann, A. and Dettmers, C. (2014) Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study. Frontiers in Neurology, 5, 279.

[15]   Sehle, A., Mundermann, A., Starrost, K., Sailer, S., Becher, I., Dettmers, C., et al. (2011) Objective Assessment of Motor Fatigue in Multiple Sclerosis Using Kinematic Gait Analysis: A Pilot Study. Journal of Neuroengineering and Rehabilitation, 8, 59.

[16]   Dettmers, C., Sulzmann, M., Ruchay-Plossl, A., Gutler, R. and Vieten, M. (2009) Endurance Exercise Improves Walking Distance in MS Patients with Fatigue. Acta Neurologica Scandinavica, 120, 251-257.

[17]   Moreira Bde, S., Dos Anjos, D.M., Pereira, D.S., Sampaio, R.F., Pereira, L.S., Dias, R.C., et al. (2016) The Geriatric Depression Scale and the Timed up and Go Test Predict Fear of Falling in Community-Dwelling Elderly Women with Type 2 Diabetes Mellitus: A Cross-Sectional Study. BMC Geriatrics, 16, 56.

[18]   Gor-Garcia-Fogeda, M.D., Cano de la Cuerda, R., Carratala Tejada, M., Alguacil-Diego, I.M. and Molina-Rueda, F. (2016) Observational Gait Assessments in People with Neurological Disorders: A Systematic Review. Archives of Physical Medicine and Rehabilitation, 97, 131-140.

[19]   Brandler, T.C., Wang, C., Oh-Park, M., Holtzer, R. and Verghese, J. (2012) Depressive Symptoms and Gait Dysfunction in the Elderly. American Journal of Geriatric Psychiatry, 20, 425-432.

[20]   Gijbels, D., Alders, G., Van Hoof, E., Charlier, C., Roelants, M., Broekmans, T., et al. (2010) Predicting Habitual Walking Performance in Multiple Sclerosis: Relevance of Capacity and Self-Report Measures. Multiple Sclerosis, 16, 618-626.

[21]   Stellmann, J.P., Neuhaus, A., Gotze, N., Briken, S., Lederer, C., Schimpl, M., et al. (2015) Ecological Validity of Walking Capacity Tests in Multiple Sclerosis. PLoS ONE, 10, e0123822.